These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11053933)

  • 1. Leucoderma associated with the use of topical minoxidil: a report of two cases.
    Malakar S; Dhar S
    Dermatology; 2000; 201(2):183-4. PubMed ID: 11053933
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical minoxidil sensitization in androgenic alopecia.
    van der Willigen AH; Dutrée-Meulenberg RO; Stolz E; Geursen-Reitsma AM; van Joost T
    Contact Dermatitis; 1987 Jul; 17(1):44-5. PubMed ID: 2958212
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis from minoxidil: study of the cross-reaction to minoxidil.
    Suzuki K; Suzuki M; Akamatsu H; Matsungaga K
    Am J Contact Dermat; 2002 Mar; 13(1):45-6. PubMed ID: 11911107
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic contact dermatitis from minoxidil.
    Valsecchi R; Cainelli T
    Contact Dermatitis; 1987 Jul; 17(1):58-9. PubMed ID: 2958222
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
    Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N
    Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis to minoxidil.
    Degreef H; Hendrickx I; Dooms-Goossens A
    Contact Dermatitis; 1985 Sep; 13(3):194-5. PubMed ID: 2932293
    [No Abstract]   [Full Text] [Related]  

  • 7. Pustular dermatosis of the scalp due to topical minoxidil 5.
    El Anzi O; Hassam B
    Pan Afr Med J; 2018; 30():83. PubMed ID: 30344867
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients.
    Scheman AJ; West DP; Hordinksy MK; Osburn AH; West LE
    Contact Dermatitis; 2000 Apr; 42(4):241. PubMed ID: 10750861
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-inflammatory depigmentation caused by Basic Blue 75.
    Sasaki Y; Uchi H; Furue M; Matsunaga K
    Contact Dermatitis; 2019 Aug; 81(2):141-143. PubMed ID: 30843217
    [No Abstract]   [Full Text] [Related]  

  • 10. Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution.
    Guarneri C; Cannavò SP
    Int J Dermatol; 2013 Apr; 52(4):507-9. PubMed ID: 22040279
    [No Abstract]   [Full Text] [Related]  

  • 11. Scalp comedones after topical minoxidil.
    Baral J
    J Am Acad Dermatol; 1985 Dec; 13(6):1051-2. PubMed ID: 2934443
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact dermatitis to minoxidil.
    Tosti A; Bardazzi F; De Padova MP; Caponeri GM; Melino M; Veronesi S
    Contact Dermatitis; 1985 Oct; 13(4):275-6. PubMed ID: 4085233
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid.
    Fisher AA
    Cutis; 1993 Jan; 51(1):17-8. PubMed ID: 8419103
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical leukoderma.
    O'Reilly KE; Patel U; Chu J; Patel R; Machler BC
    Dermatol Online J; 2011 Oct; 17(10):29. PubMed ID: 22031655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country.
    Ghosh S; Mukhopadhyay S
    Br J Dermatol; 2009 Jan; 160(1):40-7. PubMed ID: 18782317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persistent reaction to minoxidil skin patch testing mimicking pseudolymphoma].
    Schmutz JL
    Ann Dermatol Venereol; 2015 Nov; 142(11):724-5. PubMed ID: 26283422
    [No Abstract]   [Full Text] [Related]  

  • 17. Persisting allergic patch test reaction to minoxidil manifested as cutaneous lymphoid hyperplasia.
    García-Rodiño S; Espasandín-Arias M; Suárez-Peñaranda JM; Rodríguez-Granados MT; Vázquez-Veiga H; Fernández-Redondo V
    Contact Dermatitis; 2015 Jun; 72(6):413-6. PubMed ID: 25801327
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of proper vehicle selection in the detection of minoxidil sensitivity.
    Whitmore SE
    Arch Dermatol; 1992 May; 128(5):653-6. PubMed ID: 1533501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic use of topical minoxidil.
    DeVillez RL
    Dermatol Clin; 1990 Apr; 8(2):367-75. PubMed ID: 2191807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.